We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+514.19%
AUM
$3.68B
AUM Growth
-$209M
Cap. Flow
-$341M
Cap. Flow %
-9.26%
Top 10 Hldgs %
13.58%
Holding
1,437
New
112
Increased
524
Reduced
590
Closed
111

Sector Composition

Rank Sector Weight
1 Miscellaneous 18.76%
2 Technology 13.04%
3 Healthcare 11.56%
4 Financials 11.33%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPN icon
1001
Global Payments
GPN
$22.7B
$347K 0.01%
3,114
-354
-10% -$40K
HAIN icon
1002
Hain Celestial
HAIN
$53.5M
$346K 0.01%
+11,600
New +$333K
TGE
1003
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$344K 0.01%
+15,528
New +$329K
NEA icon
1004
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.14B
$343K 0.01%
26,351
+803
+3% +$10.4K
NAGE
1005
Niagen Bioscience
NAGE
$237M
$343K 0.01%
92,500
CTXS
1006
DELISTED
Citrix Systems Inc
CTXS
$343K 0.01%
+3,266
New +$336K
FINX icon
1007
Global X FinTech ETF
FINX
$160M
$341K 0.01%
13,090
+1,217
+10% +$30.4K
MLPA icon
1008
Global X MLP ETF
MLPA
$2.34B
$340K 0.01%
6,191
-1,193
-16% -$65.2K
TNL icon
1009
Travel + Leisure Co
TNL
$3.93B
$338K 0.01%
7,632
-11,324
-60% -$559K
WCN
1010
Waste Connections
WCN
$39.4B
$338K 0.01%
4,485
+45
+1% +$3.36K
SNP
1011
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$337K 0.01%
3,751
+109
+3% +$10.4K
ACIA
1012
DELISTED
Acacia Communications Inc
ACIA
$336K 0.01%
+9,650
New +$315K
TD icon
1013
Toronto Dominion Bank
TD
$197B
$335K 0.01%
5,776
+292
+5% +$16.7K
TRHC
1014
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$335K 0.01%
+5,249
New +$257K
VMO icon
1015
Invesco Municipal Opportunity Trust
VMO
$622M
$334K 0.01%
28,450
+850
+3% +$9.95K
EWW icon
1016
iShares MSCI Mexico ETF
EWW
$1.67B
$333K 0.01%
+7,064
New +$340K
NBIX icon
1017
Neurocrine Biosciences
NBIX
$15.2B
$332K 0.01%
3,377
-159
-4% -$14.2K
DWX icon
1018
State Street SPDR S&P International Dividend ETF
DWX
$523M
$331K 0.01%
8,647
-15,163
-64% -$600K
VLRS
1019
Controladora Vuela Compania de Aviacion
VLRS
$720M
$329K 0.01%
64,800
-25,000
-28% -$156K
KTOS icon
1020
Kratos Defense & Security Solutions
KTOS
$8.8B
$328K 0.01%
28,500
+1,000
+4% +$11K
HEP
1021
DELISTED
Holly Energy Partners, L.P.
HEP
$328K 0.01%
11,609
-341
-3% -$9.92K
NEV
1022
DELISTED
NUVEEN ENHANCED MUNICIPAL VALUE FUND
NEV
$328K 0.01%
24,034
-700
-3% -$9.44K
BATRK icon
1023
Atlanta Braves Holdings Series B
BATRK
$3.25B
$327K 0.01%
12,676
-138
-1% -$3.33K
SCOR icon
1024
Comscore
SCOR
$76.2M
$327K 0.01%
+750
New +$353K
IHE icon
1025
iShares US Pharmaceuticals ETF
IHE
$1.61B
$326K 0.01%
6,453
-69
-1% -$3.42K

Similar funds

Oppenheimer & Co's Q2 2018 Portfolio in Review

As of Q2 2018, Oppenheimer & Co held 1,437 positions worth $3.68B, down 5.4% from $3.89B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $341M in Q2 2018, closing 111 positions and reducing 590 holdings. Its most notable exit was Monsanto Co, an estimated $9.28M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Oppenheimer & Co opened a new position in Thor Industries worth $3.01M.

  • Oppenheimer & Co's largest Q2 2018 buy was Thor Industries: 30,900 shares worth $3.01M.
  • Oppenheimer & Co added most to AT&T in Q2 2018, an estimated $7.02M increase.
  • Oppenheimer & Co's biggest Q2 2018 reduction was Foundation Medicine, Inc., cutting an estimated $63.6M.
  • Oppenheimer & Co fully exited Monsanto Co in Q2 2018, selling an estimated $9.28M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.68B portfolio in Q2 2018.
  • Oppenheimer & Co opened 112 new positions and closed 111 in Q2 2018.
  • Oppenheimer & Co's portfolio value fell 5.4% quarter-over-quarter to $3.68B.

Based on Oppenheimer & Co's 13F filing for Q2 2018, filed 10 Aug 2018.